2 days ago
1
Pgiam/iStock via Getty Images
KeyBanc Capital Markets has initiated the coverage of Lifecore Biomedical (NASDAQ:LFCR) with a Sector Weight recommendation, noting a balanced outlook for the contract drug manufacturer’s growth prospects.
Analyst Paul Knight argued that Lifecore’s (NASDAQ:LFCR) focus, the fill/finish side of the
English (US) ·